Brief: Biodelivery Sciences Says On March 1, Bdsi Filed Complaint For Patent Infringement In Delaware
March 4 (Reuters) - BioDelivery Sciences International Inc
BDSI.O :
* BIODELIVERY SCIENCES INTERNATIONAL - ON MARCH 1, 2019,
BDSI
FILED A COMPLAINT FOR PATENT INFRINGEMENT IN DELAWARE - SEC
FILING
* BIODELIVERY SCIENCES INTERNATIONAL - COMPLAINT WAS FILED
AGAINST
CHEMO RESEARCH, S.L., INSUD PHARMA S.L., INTELGENX CORP., AND
INTELGENX TECHNOLOGIES
* BIODELIVERY SCIENCES INTERNATIONAL - BELIEVES THAT IT WILL
BE
ABLE TO PREVAIL IN PATENT INFRINGEMENT LAWSUIT
Source text: (https://bit.ly/2ELvW6S)
Further company coverage: BDSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA